CADL R&D Expenses

Candel Therapeutics Inc · R&D Expenses

CADL logo

CADL R&D Expenses

Latest reported$49.13M
CADL TTM R&D Expenses ($8.76M → $49.13M)
High-resolution chart · PNG

CADL r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Candel Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
49,130,000
36,320,000
30,496,000
24,285,000
21,240,000
19,228,000
19,314,000
21,755,000
22,184,000
23,139,000
24,506,000
21,944,000
21,475,000
20,563,000
20,511,000
19,491,000
19,380,000
17,650,000
14,986,000
14,844,000
11,392,000
9,895,000
8,763,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.